HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wang Liang Selected Research

Infections

7/2013Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.
4/2011Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wang Liang Research Topics

Disease

5Neoplasms (Cancer)
07/2023 - 09/2009
3Inflammation (Inflammations)
02/2024 - 01/2021
2Neoplasm Metastasis (Metastasis)
07/2023 - 09/2009
2Obesity
09/2022 - 12/2010
2Carcinogenesis
08/2019 - 09/2009
2Infections
07/2013 - 04/2011
2Glomerulonephritis
12/2009 - 11/2008
1Postmenopausal Osteoporosis
02/2024
1Osteoporosis
02/2024
1Glioma (Gliomas)
07/2023
1Dysbiosis
09/2022
1Pathologic Processes
08/2019
1Intracranial Aneurysm (Cerebral Aneurysm)
02/2019
1Neuroblastoma
09/2014
1Atherosclerotic Plaque (Atheroma)
09/2013
1Weight Gain
12/2010
1Pre-Eclampsia (Preeclampsia)
06/2010
1Acute Lung Injury
01/2008
1Brain Ischemia (Cerebral Ischemia)
07/2004

Drug/Important Bio-Agent (IBA)

3lipoprotein-associated coagulation inhibitor (TFPI)IBA
12/2009 - 01/2008
2Proteins (Proteins, Gene)FDA Link
07/2023 - 12/2009
2NF-kappa B (NF-kB)IBA
09/2022 - 01/2021
2tissue-factor-pathway inhibitor 2 (PP5)IBA
09/2013 - 06/2010
1Estrogens (Estrogen)FDA Link
02/2024
1SincalideFDA Link
07/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2023
1Polysaccharides (Glycans)IBA
09/2022
1Nitric Oxide Synthase (NO Synthase)IBA
09/2022
1Toll-Like Receptor 4IBA
09/2022
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
08/2019
15,6,7,8- tetrahydro- 4H- isoxazolo(4,5- d)azepin- 3- olIBA
08/2019
1Fluorescent Dyes (Fluorescent Probes)IBA
08/2019
1erucylphosphocholineIBA
02/2019
1Indicators and Reagents (Reagents)IBA
01/2018
1acetamideIBA
09/2014
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
09/2014
1Protein Kinase InhibitorsIBA
09/2014
1Matrix Metalloproteinases (MMPs)IBA
09/2013
1Apolipoproteins E (ApoE)IBA
09/2013
1nemonoxacinIBA
07/2013
1Anti-Bacterial Agents (Antibiotics)IBA
04/2011
1LipidsIBA
12/2010
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2010
1Thromboplastin (Tissue Factor)IBA
06/2010
1Peptides (Polypeptides)IBA
12/2009
1Transforming Growth Factor beta (TGF-beta)IBA
09/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
1NeuroserpinIBA
07/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2004
1Neuroprotective AgentsIBA
07/2004
1Messenger RNA (mRNA)IBA
07/2004
1Tissue Plasminogen Activator (Alteplase)FDA Link
07/2004
1Plasminogen Activators (Plasminogen Activator)IBA
07/2004
1Plasminogen Activator Inhibitor 1IBA
07/2004

Therapy/Procedure

2Therapeutics
02/2024 - 07/2023
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2024
1Transplantation
07/2023
1Drug Therapy (Chemotherapy)
08/2019